Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 66270-97-1 | MDL No. : | MFCD00009632 |
Formula : | C17H15BrO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | - |
M.W : | 347.20 | Pubchem ID : | - |
Synonyms : |
|
Num. heavy atoms : | 21 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.18 |
Num. rotatable bonds : | 7 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 84.86 |
TPSA : | 43.37 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.81 cm/s |
Log Po/w (iLOGP) : | 2.82 |
Log Po/w (XLOGP3) : | 3.68 |
Log Po/w (WLOGP) : | 3.4 |
Log Po/w (MLOGP) : | 3.29 |
Log Po/w (SILICOS-IT) : | 4.62 |
Consensus Log Po/w : | 3.56 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.27 |
Solubility : | 0.0186 mg/ml ; 0.0000535 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -4.28 |
Solubility : | 0.0182 mg/ml ; 0.0000524 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -6.58 |
Solubility : | 0.0000911 mg/ml ; 0.000000262 mol/l |
Class : | Poorly soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.39 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 7500-37-0 ]
2-(4-Bromophenyl)-2-oxoethyl acetate
Similarity: 0.81
[ 7398-42-7 ]
Methyl 2-(4-(bromomethyl)phenyl)acetate
Similarity: 0.81
[ 20201-26-7 ]
Ethyl 2-(4-bromophenyl)-2-oxoacetate
Similarity: 0.80
[ 57699-28-2 ]
Methyl 2-(4-bromophenyl)-2-oxoacetate
Similarity: 0.77
[ 7500-37-0 ]
2-(4-Bromophenyl)-2-oxoethyl acetate
Similarity: 0.81
[ 7398-42-7 ]
Methyl 2-(4-(bromomethyl)phenyl)acetate
Similarity: 0.81
[ 20201-26-7 ]
Ethyl 2-(4-bromophenyl)-2-oxoacetate
Similarity: 0.80
[ 57699-28-2 ]
Methyl 2-(4-bromophenyl)-2-oxoacetate
Similarity: 0.77
[ 122394-38-1 ]
Methyl 2-(2-bromophenyl)-2-oxoacetate
Similarity: 0.77
[ 7500-37-0 ]
2-(4-Bromophenyl)-2-oxoethyl acetate
Similarity: 0.81
[ 7398-42-7 ]
Methyl 2-(4-(bromomethyl)phenyl)acetate
Similarity: 0.81
[ 20201-26-7 ]
Ethyl 2-(4-bromophenyl)-2-oxoacetate
Similarity: 0.80
[ 57699-28-2 ]
Methyl 2-(4-bromophenyl)-2-oxoacetate
Similarity: 0.77
[ 7500-37-0 ]
2-(4-Bromophenyl)-2-oxoethyl acetate
Similarity: 0.81
[ 20201-26-7 ]
Ethyl 2-(4-bromophenyl)-2-oxoacetate
Similarity: 0.80
[ 57699-28-2 ]
Methyl 2-(4-bromophenyl)-2-oxoacetate
Similarity: 0.77
[ 122394-38-1 ]
Methyl 2-(2-bromophenyl)-2-oxoacetate
Similarity: 0.77
[ 7398-42-7 ]
Methyl 2-(4-(bromomethyl)phenyl)acetate
Similarity: 0.81
[ 114772-38-2 ]
Methyl 2-[4-(Bromomethyl)phenyl]benzoate
Similarity: 0.75
[ 114772-40-6 ]
2-Boc-4'-(Bromomethyl)biphenyl
Similarity: 0.72
[ 56427-63-5 ]
Ethyl 2-(bromomethyl)-4-methoxybenzoate
Similarity: 0.72
[ 13737-36-5 ]
4-(Bromomethyl)phenylacetic acid
Similarity: 0.71